TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 96 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $4,475,000 | -1.9% | 94,321 | -24.3% | 0.52% | -0.6% |
| Q1 2015 | $4,563,000 | -32.5% | 124,525 | -26.9% | 0.53% | -44.1% |
| Q4 2014 | $6,760,000 | +122.1% | 170,240 | +11.6% | 0.94% | +52.3% |
| Q3 2014 | $3,044,000 | +76.6% | 152,595 | +19.7% | 0.62% | +100.3% |
| Q4 2013 | $1,724,000 | +18.1% | 127,495 | -0.6% | 0.31% | +6.2% |
| Q3 2013 | $1,460,000 | – | 128,312 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 354,300 | $7,068,000 | 2.77% |
| Opaleye Management Inc. | 169,700 | $3,385,515,000 | 2.64% |
| Broadfin Capital, LLC | 959,247 | $19,137,000 | 2.01% |
| Novo Holdings A/S | 900,000 | $17,955,000 | 1.75% |
| Eventide Asset Management | 300,900 | $6,003,000 | 0.84% |
| EAM Investors, LLC | 152,595 | $3,044,000 | 0.62% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 497,858 | $9,932,000 | 0.51% |
| Granite Point Capital Management, L.P. | 40,000 | $798,000 | 0.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,191 | $8,981,000 | 0.33% |
| TFS CAPITAL LLC | 133,070 | $2,655,000 | 0.23% |